Amid national furor over abortion, the Food and Drug Administration permanently removed a controversial restriction on access to abortion pills by allowing patients to receive the medicine by mail, instead of requiring them to get the pills in person from specially certified providers.
The decision means that medication abortion may become more widely available to women who find it difficult to travel to abortion providers. Going forward, any doctor who is certified to prescribe the pill, which is known as mifepristone, can do so online and have it sent by mail, which will allow pregnancies to be terminated at home, even if the U.S. Supreme Court strikes down Roe v. Wade. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What’s included? Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. This name will appear with your comment
https://www.statnews.com/pharmalot/2021/12/16/fda-abortion-mifreprex-mifepristone/
